Dynamine 3 as a diagnostic and prognostic biomarker in pancreatic cancer: Implications for early detection and targeted therapy
The DNM3 gene may play a tumor suppressor role in pancreatic cancer, similar to its role in other malignancies. The contribution of immune cells may also be significant in this effect. However, in vitro studies are needed to elucidate the mechanisms triggered in pancreatic cancer.
Authors
- Fatih Yay (ORCID: https://orcid.org/0000-0002-1872-8716)
- Fatih Kuş (ORCID: https://orcid.org/0000-0003-1650-154X)
- Hasan Çağrı Yıldırım (ORCID: https://orcid.org/0000-0003-3060-377X)
- Şuayib Yalçın
Institutions
- Niğde Ömer Halisdemir Üniversitesi (TR)
- Hacettepe University (TR)
Publication Details
- Journal
- Biomarkers
- Published
- 2025-01-23
- DOI
- https://doi.org/10.1080/1354750x.2025.2458104
- Primary Topic
- Endoplasmic Reticulum Stress and Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00